Laddar...
Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab
Multiple sclerosis is a frequent neurologic disease, which causes sensory impairment, fatigue, cognitive deficits, imbalance, loss of mobility, spasticity, and bladder and bowel dysfunction. Several new therapies have been introduced in the past decade, but additional drugs are needed to slow diseas...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2009
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3169988/ https://ncbi.nlm.nih.gov/pubmed/21935306 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|